FUSITAB

USPTO USPTO 2000 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark FUSITAB was filed as Word mark on 10/16/2000 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 08/05/2003. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details Last update: August 21, 2019

Trademark form Word mark
File reference 78030862
Register number 2747063
Application date October 16, 2000
Publication date July 2, 2002
Entry date August 5, 2003

Trademark owner

Robert Robinson Avenue The Oxford Science Park
OX4 4GA Oxford
GB

Trademark representatives

goods and services

5 Gene therapy and prophylaxis products, namely, clinical, medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents/nucleic acid/antibodies for gene therapy; vaccines; enzymes and enzyme preparations for medical purposes, namely, gene therapy for use in the treatment of viral and bacterial infections, cancer and bodily conditions associated with immunosystems
10 instruments, apparatus surgical and medical apparatus and instruments, all for the administration of gene therapy treatment and for the administration of prophylaxis products, namely, syringes, scalpels, catheters, and tubes for the administration of gene therapy products
42 Scientific and medical research and product development; medical services; genetic engineering services; biotechnology services, namely, research and development of new products in the field of biotechnology; scientific and medical research and development of new products in the field of gene therapy

ID: 1378030862